Towards finding a population biomarker for wastewater epidemiology studies

Science of the Total Environment

Volumn 487, Issue 1, 2014, Pages 621-628

  Chen, Chang ^a,c   Kostakis, Chris ^b   Gerber, Jacobus P ^c   Tscharke, Ben J ^c   Irvine, Rodney J ^a   White, Jason M ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b FORENSIC SCIENCE SA   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

5 HIAA; Biomarker; Cotinine; Indicator; Population; Wastewater

Indexed keywords

BIOMARKERS; CHOLESTEROL; CORTISOL; INDICATORS (INSTRUMENTS); PHYSIOLOGY; WASTEWATER;

5-HIAA; COTININE; INTERNATIONAL COMPARISON; NEUROTRANSMITTER METABOLITES; OBJECTIVE INFORMATION; POPULATION; POPULATION ESTIMATIONS; QUANTIFICATION METHODS;

SURVEYS;

5 HYDROXYINDOLEACETIC ACID; ANDROSTENEDIONE; CHOLESTEROL; COPROSTEROL; COTININE; CREATININE; HYDROCORTISONE;

BIOINDICATOR; BIOMARKER; DRUG; EPIDEMIOLOGY; METABOLITE; PARTICULATE MATTER; POPULATION ESTIMATION; WASTEWATER;

ADSORPTION; ARTICLE; BINDING AFFINITY; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); LIMIT OF QUANTITATION; PARTICULATE MATTER; POLLUTION MONITORING; POPULATION; PRIORITY JOURNAL; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT;

5-HIAA; BIOMARKER; COTININE; INDICATOR; POPULATION; WASTEWATER;

BIOLOGICAL MARKERS; COTININE; HYDROXYINDOLEACETIC ACID; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL; WATER POLLUTION, CHEMICAL;

EID: 84900828171     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.11.075     Document Type: Article

References (39)

1. American Chemical Society SciFinder. American Chemical Society 2013.
2. Australian Institute of Health and Welfare 2007 National Drug Strategy Household Survey: detailed findings 2008, AIHW, Canberra.
3. Baker D.R., Kasprzyk-Hordern B. Critical evaluation of methodology commonly used in sample collection, storage and preparation for the analysis of pharmaceuticals and illicit drugs in surface water and wastewater by solid phase extraction and liquid chromatography-mass spectrometry. J Chromatogr A 2011, 1218:8036-8059.
4. Baker D.R., Kasprzyk-Hordern B. Multi-residue analysis of drugs of abuse in wastewater and surface water by solid-phase extraction and liquid chromatography-positive electrospray ionisation tandem mass spectrometry. J Chromatogr A 2011, 1218:1620-1631.
5. Biradar S.B., Kallaganad G.S., Rangappa M., Kashinakunti S.V., Retnakaran R. Correlation of spot urine protein-creatinine ratio with 24-hour urinary protein in type 2 diabetes mellitus patients: a cross sectional study. J Res Med Sci 2011, 16:634-639.
6. Bisceglia K.J. Occurrence and fate of pharmaceuticals, illicit drugs, and other emerging contaminants in natural and engineered environments 2010, 397. Ph.D, The Johns Hopkins University, Baltimore.
7. Castiglioni S., Zuccato E., Chiabrando C., Fanelli R., Bagnati R. Mass spectrometric analysis of illicit drugs in wastewater and surface water. Mass Spectrom Rev 2008, 27:378-394.
8. Castiglioni S., Bijlsma L., Covaci A., Emke E., Hernandez F., Reid M., et al. Evaluation of uncertainties associated with the determination of community drug use through the measurement of sewage drug biomarkers. Environ Sci Technol 2013, 47:1452-1460.
9. Chang H., Hu J., Shao B. Occurrence of natural and synthetic glucocorticoids in sewage treatment plants and receiving river waters. Environ Sci Technol 2007, 41:3462-3468.
10. Chang H., Wan Y., Wu S., Fan Z., Hu J. Occurrence of androgens and progestogens in wastewater treatment plants and receiving river waters: comparison to estrogens. Water Res 2011, 45:732-740.
11. Chen C., Kostakis C., Harpas P., Felgate P.D., Irvine R.J., White J.M. Marked decline in 3,4-methylenedioxymethamphetamine (MDMA) based on wastewater analysis. J Stud Alcohol Drugs 2011, 72:737-740.
12. Chen C., Kostakis C., Irvine R.J., Felgate P.D., White J.M. Evaluation of pre-analysis loss of dependent drugs in wastewater: stability and binding assessments. Drug Test Anal 2013, 5:716-721.
13. Chen C., Kostakis C., Irvine R.J., White J.M. Increases in use of novel synthetic stimulant are not directly linked to decreased use of 3,4-methylenedioxy-N-methylamphetamine (MDMA). Forensic Sci Int 2013, 231:278-283.
14. Chiaia A.C., Banta-Green C., Field J. Eliminating solid phase extraction with large-volume injection LC/MS/MS: analysis of illicit and legal drugs and human urine indicators in U.S. wastewaters. Environ Sci Technol 2008, 42:8841-8848.
15. Curtin F., Walker J.P., Schulz P. Day-to-day intraindividual reliability and interindividual differences in monoamines excretion. J Affect Disord 1996, 38:173-178.
16. Daughton C.G. Illicit drugs in municipal sewage: proposed new non-intrusive tool to heighten public awareness of societal use of illicit/abused drugs and their potential for ecological consequences. Pharmaceuticals and personal care products in the environment: scientific and regulatory issue 2001, 348-364. American Chemical Society, Washington, D. C. T.L. Jones-Lepp (Ed.).
17. Daughton C.G. Real-time estimation of small-area populations with human biomarkers in sewage. Sci Total Environ 2012, 414:6-21.
18. Deo R.P., Halden R.U. Effect of sample filtration on the quality of monitoring data reported for organic compounds during wastewater treatment. J Environ Monit 2010, 12:478-483.
19. Edwards A.C., Withers P.J.A. Linking phosphorus sources to impacts in different types of water body. Br Soc Soil Sci 2007, 23(Suppl. 1):133-143.
20. Feldman J.M., Lee E.M. Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid. Am J Clin Nutr 1985, 42:639-643.
21. Heidler J., Halden R.U. Meta-analysis of mass balances examining chemical fate during wastewater treatment. Environ Sci Tech 2008, 42:6324-6332.
22. Irvine R.J., Kostakis C., Felgate P.D., Jaehne E.J., Chen C., White J.M. Population drug use in Australia: a wastewater analysis. Forensic Sci Int 2011, 210:69-73.
23. James E., Kleinman P., Veith T., Stedman R., Sharpley A. Phosphorus contributions from pastured dairy cattle to streams of the Cannonsville Watershed, New York. J Soil Water Conserv 2007, 62(1):40-47. [January/February].
24. Kema I.P., Schellings A.M., Meiborg G., Hoppenbrouwers C.J., Muskiet F.A. Influence of a serotonin- and dopamine-rich diet on platelet serotonin content and urinary excretion of biogenic amines and their metabolites. Clin Chem 1992, 38:1730-1736.
25. Khan U., Nicell J.A. Refined sewer epidemiology mass balances and their application to heroin, cocaine and ecstasy. Environ Int 2011, 13:1236-1252.
26. Khan U., Nicell J.A. Sewer epidemiology mass balances for assessing the illicit use of methamphetamine, amphetamine and tetrahydrocannabinol. Sci Total Environ 2012, 421-422:144-162.
27. Lai F.Y., Ort C., Gartner C., Carter S., Prichard J., Kirkbride P., et al. Refining the estimation of illicit drug consumptions from wastewater analysis: co-analysis of prescription pharmaceuticals and uncertainty assessment. Water Res 2011, 45:4437-4448.
28. Larrarte F., Pons M.N. Suspended solids concentration in wastewater: influence of sampling conditions. Urban Water J 2011, 8:397-404.
29. Miki K., Sudo A. Effect of urine pH, storage time, and temperature on stability of catecholamines, cortisol, and creatinine. Clin Chem 1998, 44:1759-1762.
30. Ort C., Lawrence M.G., Reungoat J., Mueller J.F. Sampling for PPCPs in wastewater systems: comparison of different sampling modes and optimization strategies. Environ Sci Technol 2010, 44:6289-6296.
31. Pesce A., West C., West R., Crews B., Mikel C., Rosenthal M., et al. Determination of medication cutoff values in a pain patient population. J Opioid Manag 2011, 7:117-122.
32. Reid M.J., Langford K.H., Morland J., Thomas K.V. Quantitative assessment of time dependent drug-use trends by the analysis of drugs and related metabolites in raw sewage. Drug Alcohol Depend 2011, 119:179-186.
33. SA Water SA Water annual report 07-08 2008.
34. Sharma A.M., Schorr U., Thiede H.M., Distler A. Effect of dietary salt restriction on urinary serotonin and 5-hydroxyindoleacetic acid excretion in man. J Hypertens 1993, 11:1381-1386.
35. Soliman S.A., Abdel-Hay M.H., Sulaiman M.I., Tayeb O.S. Stability of creatinine, urea and uric acid in urine stored under various conditions. Clin Chim Acta 1986, 160:319-326.
36. van Faassen A., Bol J., van Dokkum W., Pikaar N.A., Ockhuizen T., Hermus R.J. Bile acids, neutral steroids, and bacteria in feces as affected by a mixed, a lacto-ovovegetarian, and a vegan diet. Am J Clin Nutr 1987, 46:962-967.
37. van Nuijs A.L., Mougel J.F., Tarcomnicu I., Bervoets L., Blust R., Jorens P.G., et al. Sewage epidemiology-a real-time approach to estimate the consumption of illicit drugs in Brussels, Belgium. Environ Int 2011, 37:612-621.
38. Zuccato E., Chiabrando C., Castiglioni S., Bagnati R., Fanelli R. Estimating community drug abuse by wastewater analysis. Environ Health Perspect 2008, 116:1027-1032.
39. Zuetenhorst J.M., Korse C.M., Bonfrer J.M., Peter E., Lamers C.B., Taal B.G. Daily cyclic changes in the urinary excretion of 5-hydroxyindoleacetic acid in patients with carcinoid tumors. Clin Chem 2004, 50:1634-1639.